Medicine and Dentistry
Infarction
100%
Acute Heart Infarction
99%
Diabetes
92%
Angioplasty
90%
Cardiovascular System
84%
Cardiovascular Disease
78%
Revascularization
75%
Salt Intake
75%
Placebo
72%
Transluminal Coronary Angioplasty
50%
Heart Failure
50%
Prevalence
42%
Blood Pressure
41%
Myocardial Infarction
40%
Echocardiography
35%
Tissue Plasminogen Activator
35%
Heart Left Ventricle Function
33%
Body Mass Index
31%
Electrocardiogram
30%
Low Density Lipoprotein Cholesterol
27%
Alteplase
25%
Physical Activity
25%
Central Sleep Apnea
25%
Chronic Disease
25%
Constipation
25%
Edetic Acid
25%
Sudden Infant Death Syndrome
25%
Telemedicine
25%
Coronary Risk
25%
Glycemic Control
25%
Dermatoglyphics
25%
Thorax Pain
25%
Finger Dermatoglyphics
25%
Nifedipine
25%
SYNTAX Score
25%
Abdominal Pain
25%
Blood Clot Lysis
25%
Digoxin
25%
Mitral Valve Repair
25%
Symptomatic Treatment
25%
Sinus Rhythm
25%
Counterpulsation
25%
Breathing
25%
Chelation Therapy
25%
Diabetic Neuropathy
25%
Patient Monitoring
25%
Ejection Fraction
24%
Sodium Chloride
24%
Coronary Artery Disease
23%
Symptom
22%
Keyphrases
Angioplasty
91%
Myocardial Infarction
78%
Cardiovascular Prevention
75%
Revascularization
75%
Type 2 Diabetes Mellitus (T2DM)
75%
Dietary Salt
75%
Congestive Heart Failure
72%
Heart Failure
68%
Confidence Interval
55%
Acute Myocardial Infarction
54%
Randomized Trial
50%
Monkey
50%
Digoxin
50%
Heart Rate
50%
Blood Pressure
46%
Placebo
45%
Risk Ratio
39%
Hypertensive
37%
Cardiovascular Events
35%
Ischemic Heart Disease
30%
Treadmill
28%
Patients with Diabetes
28%
SYNTAX Score
25%
Sudden Infant Death Syndrome
25%
Inverse Relation
25%
Ischemia
25%
Functional Comparison
25%
Fat Distribution
25%
Physical Activity
25%
Fatness
25%
Chelation Therapy
25%
Aprindine
25%
Relative Risk
25%
Patients with Heart Failure
25%
Aerobic Performance
25%
Ventricular Ischemia
25%
Telemedicine
25%
Size Expansion
25%
Quinolinone Derivatives
25%
Atherothrombotic Risk
25%
Fingerprint Evidence
25%
Healthcare Interventions
25%
Elective Coronary Angioplasty
25%
Inotropic Agents
25%
Waist Circumference
25%
Cardiac Patients
25%
Placebo-controlled
25%
BARI 2D
25%
LDL-C Target
25%
Therapy Effect
25%